chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Sometime after my fifth dose of my Moderna COVID-19 vaccine I was having shortness of breath and I was also having a pretty low pulse. I was feeling like I was hyperventilating. I went to my cardiologist who ordered an echocardiogram and a heart monitor. I am still waiting on the heart monitor that I'm supposed to wear for month, and I will see her again on 10/31/2022. I also experienced arm soreness with a hard knot in my arm at injection site. It was hot to the touch, and it lasted around 4 days before it went away on its own.
severe pain in left arm and shoulder and neck semi bedridden for 6 days required narcotic pain killers  cold packs and anti-inflammatories
Information has been received from a physician concerning a 35 year old pt who was vaccinated with a dose of hep B virus vaccine. The reporter indicated that the pt may have developed a thrombocytopenia and noted that "the pt's platelet count of one year ago was approximately 160K while this year was a few thousand below our lab's normal of 150K." It was noted that the pt is otherwise unremarkable. Unspecified medical attention. Additional info has been requested.
Tinnitus in left ear  Thought was allergy related so prescribed Methylpred 4mg Pack + Flonase + Claratin but no relief
Information has been received from a nurse practitioner, concerning a female patient (age not specified), who on an unknown date was vaccinated IM with a dose of Gardasil vaccine (lot # not reported). Subsequently, the patient developed a minor injection site reaction that involved redness at the injection site. The patient was seen by the physician (treatment not specified). After a few days, the patient recovered. This is one of two reports received from the same source (0711USA04079). Additional information has been requested.
Sunday 12/05/2021, I started to feel ill with stomach cramps and exhaustion.    Later that evening, I started running a mild fever, 100.5F and diarrhea.    I started to get head and chest congestion, too.   The symptoms continued for a few days, and congestion got worse.  On Tuesday 12/7 I tried to get appointments with both my GP and Pulmonologist, but could not reach them.   On Wednesday night (12/8-12/9) I removed my CPAP machine because it felt like breathing was more difficult with it on.    I continued to get worse congestion, and called my drug store for OTC guafenisin.  I took guafenisin, tylenol, and phenylephrine to try and deal with the symptoms.  I called my doctors office again but was unable to reach them.    On Monday 12/13 I was still unable to get an appointment for an office visit.  My symptoms were getting worse, and I was starting to panic over frequent feelings of suffocation.    I called my insurance company "ask a nurse number", and they were not at all helpful.  The next morning, I took myself to the ER.  They diagnosed me with community-acquired pneumonia after ruling out flu, covid-19 and other viruses.   They gave me IV antibiotis and steroids, then sent me home with a course of those drugs.     After about a week I was doing better, but still have some symptoms today.
Started with a sore throat and progressed to persistent cough that would keep me up at night. Didn't get better after a month so I called my PCP and they referred me to a telehealth dr. and she prescribed a pill to help with the cough to take at night. I wasn't able to sleep due to coughing. Dr. didn't think I needed to be tested for Covid due to it already being a month. Recently I had another episode on April 19th. I went to urgent care because I couldn't sleep and kept coughing and it started with a sore throat and I had just arrived back from travelling. I got tested on the 19th and it was negative for Covid, the doctor prescribed a tapered steroid which didn't do anything. I still had the cough pills from the previous year so I used it at night as needed. And I'm still dealing with the cough now, especially at night.
Information has been received from a pharmacist concerning his approx. 42 month old daughter who was vaccinated with MMRII and DTP. Subsequently, the child developed autism and the father "feels that the autism may be due to the vaccines that his child received." The child received unspecified medical attention. Upon internal review, the pt's autism was considered to be "Other Medical Event". Additional information has been requested.
3 hours after injections-pt became moody-cried all evening- didn't know why he was crying-seems quiet and ok the next day.
sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (sore arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (sore arm). At the time of the report, VACCINATION SITE PAIN (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported Treatment medications was not provided
This study case was received from the investigator on 27 August 2012. A 19 year-old male subject with no reported past medical history had received ACAM2000 (lot number, route, site of administration not reported) "just before holiday" and an unspecified amount of time later was found to have on 04 December 2009 (also reported as study day 17) an elevated Troponin, central laboratory level of 0.17 ng/mL (also with a reported date of 11 December 2009). The subject had a rapid Troponin I level on 04 December 2009 that was within normal limits (negative). The subject was asymptomatic according to the investigator. An ECG was performed on 05 January 2010 that was reported as normal. A repeat Troponin on 05 January 2010 (also reported as study day 49) remained elevated 0.14 ng/mL. The subject had no concomitant medications. No treatments were reported. The subject had reported left arm itching at injection site with a reported start date of 22 November 2009 and an end date of 29 November 2009 (also with a reported date of 04 December 2009). No further information was available at the time of the report. The subject's outcome was ongoing (not recovered). According to the investigator, the event of elevated Troponin was considered an other important event and possibly related to vaccination. Per the investigator, this represents a case of potential myopericarditis and was referred to the study's adjudication committee for assessment. Documents held by sender: medical record.
Breakthrough case of COVID, sore throat, nasal congestion, chills, fever, sweating, body aches.
Fever, pain all over body, headache for 5 days, fatigue for 5 days, nausea, join pain, sleep disturbance, lymph notes swelling in the throat
Arm became very sore a few hours after injection. Soreness went away by second morning after.
About a week after vaccination a rash start on both arms. Big blotchy hives on my forearms which spread to my thighs and progressed to hives all over my body. The rash was itchy. At Urgent care they gave me an IV of Benadryl. I was discharged after about two hours. I took Benadryl and daily Zyrtec for a week and the hives went away. I followed up with my doctor and got some allergy tests which were negative for new allergy.
Redness and swelling at injection site in the morning. Hives developed in the afternoon on his face. Hives treated with BENADRYL.
Fever and sore arm at shot site. Ibuprofen took care of the fever that day. No fever the next day. Sore arm with some swelling persisted for 2 days thereafter and subsided.
I did not administer this vaccine, I am reporting as the pharmacy manager of the location that provided the vaccine. Patient received a flu vaccine at a clinic held at her place of employment. Shortly after receiving the vaccine, she came back to the pharmacist and reported that her arm was feeling "tingly." The pharmacist informed her that it is likely nothing to worry about, but to apply ice if she is uncomfortable and to take pain relievers if it starts to become sore, and to monitor for any changes. A few days later, the patient contacted her physician because the sensation was still there, and her physician recommended she contact the pharmacy. So she got in contact with the pharmacist that held the clinic with her concerns. He informed her that this can happen if the vaccine was given near a nerve, causing the nerve and the surrounding area to become inflamed which could cause her symptoms. He told her that we would report to VAERS and for her to continue to monitor and to follow up with us with any changes.
nerve problems in left side; twitching in the eye; This spontaneous case was reported by a consumer and describes the occurrence of NERVOUS SYSTEM DISORDER (nerve problems in left side) and BLEPHAROSPASM (twitching in the eye) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NERVOUS SYSTEM DISORDER (nerve problems in left side) and BLEPHAROSPASM (twitching in the eye). At the time of the report, NERVOUS SYSTEM DISORDER (nerve problems in left side) and BLEPHAROSPASM (twitching in the eye) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. Treatment information was unknown.
VS: BP 98/76, baseline is 90/60, 98% RA, HR 73, no hives, facial/lip swelling, clear oropharynx, heart and lungs clear to auscultation, no stridor, grip strengths equal/symmetrical bilaterally, cap refill < 2 seconds  One minute after injection patient started experiencing mild right-sided itching involving the arm, neck, ear, lip and throat, dizziness and numbness of right 3rd, 4th, 5th fingers without facial/lip swelling, hives, SONB, chest pain, abdominal pain, difficulty swallowing or facial weakness, dizziness resolved Pt was advised to take PO Benadryl 25 mg, but patient declined and stated "I want to go home"  Pt was advised to seek immediate evaluation of numbness does not resolve within a few hours Pt states she will take Benadryl after she gets home, advised to seek immediate evaluation if developing symptoms of worsening allergic reaction, especially hives, difficulty breathing or sensation of throat closing
Immediate Hives, Elevated blood pressure, shortness of breath, irregular reacting pupils, left thumb numbness and inoperability  your website is infuriating. i'm trying to enter the information, it's all entered and i'm getting the error in red above. i don't belive this specific vaccine is meant to help the global public.
This case was reported by a lawyer and described the occurrence of memory loss in a 56 year old male patient who received Lyme disease vaccine recombinant OpsA (LYMErix) injection for prophylaxis. A physician or other health care professional has not verified this report. On an unspecified date, the patient received LYMErix. At an unknown time after receiving LYMErix, the patient experienced "joint pain, fatigue, tingling, memory loss, gait disturbance, disorientation, loss of concentration, peripheral neuropathy and confusion" Time to onset, treatmet and outcome were not reported.
Chills, nausea, sweating, body joint and muscle pain, headache, increased tinnitus, too sick to take my daughter to school
Marked swelling, erythema and pain extending circumferentially around injection site with tense bullae formation centrally.
2 days after flu vaccine had anaphylaxis- hives all over body, tongue and facial swelling that with treatment continued to return for 24 hours, then discharged from hospital next day as swelling seemed to stop but continued to have hives for 5 more days.
Information has been received from a nurse via company representative, referring to a patient of unknown age and gender. No relevant medical history or concurrent conditions were reported. On 24-FEB-2016 the patient was vaccinated with a dose of PNEUMOVAX 23 (dose, route, lot# and expiration date were not reported). Then on 01-MAR-2016, the patient received a dose of PREVNAR 13 (dose and route were not reported) (inappropriate schedule of drug administration). No adverse effect was reported. Additional information has been requested.
Out of Temperature Range Product Administered; Initial Report Received on 06-DEC-2022  This is a spontaneous report, received from a registered nurse regarding a 27-year-old patient who received HEPLISAV-B for hepatitis B immunisation.   There was no medical history reported for the patient.  Concomitant medications were not reported.  On 08-SEP-2022, dose 1 of HEPLISAV B (Lot #937782, expiration date 25-SEP-2023, NDC # 43528-002-01), was administered intramuscularly in the left deltoid for hepatitis B immunisation.    The vaccine was out of temperature range. The amount of time it was out of temperature range is unknown. The reporter denied any other adverse effects reported by the patient.   Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.
On 2/7/01, received RabAvert, 2nd injection of a series of 3. On 2/12/01 (5 days later), she developed hives. Series discontinued; treated for hives. No respiratory distress.
Pt recvd 2nd vax 05JUL90 & exp T-102,felt bad,achy & weak.Pt. had viral infect lasted 5 days.
Patient felt odd and lost consciousness for a short time.  Patient regained consciousness after moving to the floor and laying flat.  Patient stayed under observation with the Staff nurse, but did not have any other known complication.
pt felt lightheaded several minutes after vaccination. felt better after lying down and drinking water. pulse in the 70s throughout. lungs ctab and heart rrr. was able to ambulate without assistance. pulse did not change after standing. counseled on syncope precautions.
Pain at site of injection. Fever, chills, shakes and sweating beginning 10 hours afterwards and lasting for more than 10 hours. Unable to sleep. Muscle pain, not solely at injection site.
Severe Bloody nose, with quarter size blood clots that took more than 45 minutes to stop.  Never had a bloody nose in his life.  They told us it was from our dry house, but we had not not had the heat on.  It stopped bleeding and we went home.  Had bad headache for two days following.
Pt had tongue tingling right after the first vaccination and took Benadryl and went better. Prior to the next vaccination she took Benadryl and after felt tongue tingling again and dizziness. Pt continued Benadryl until seen by our facility today.  Today was given 120mg Solu Medrol IM and had to wait 30 minutes and showed great improvement.
This spontaneous report as received from a pharmacist refers to a 14 year old patient of unknown gender. Historical conditions, concurrent conditions and concomitant medications were not reported. On an unknown date, at the age of 12 years, the patient was vaccinated with the first dose of GARDASIL 9 (dose, route of administration, lot # and expiration date not provided) for prophylaxis. On an unknown date, at the age of 14 years, the patient received the second dose of GARDASIL 9 (dose, route of administration, lot # and expiration date not provided) for prophylaxis. No adverse effect was reported. Additional information has been requested.
Pt. states that after receiving the 3rd dose of Moderna 11/02/2021, started experiencing symptoms 11/04/2021 of extreme pain at the injection site, numbness in the Left shoulder to the elbow traveling throughout the neck, limited mobility with Both arms, and radiating pain traveling to both legs. Primary communications recommendation for Emergency Room visit 11/27/2021, diagnosed with Fibromyalgia, Blood Work/Chest X-Ray. Still experiencing mobility issues with pain continuing. Primary Follow-Up visit 11/30/2021, prescribed Tramadol/Ambien. Gabapentin 300mg recommended for Follow-Up care. Recommendation of Neurologist visit 12/2021 for full exam (Still waiting on Results). Pt. also experiencing periods of difficulty balancing resulting falls with injury.
Vaccine was given on 10/6/2010. For 3 days following vaccine, patient nasal symptoms, headache and fever. Exactly one week following vaccine (10/13/10) patient woke up and could not walk due to numbness in legs. She was hospitalized. Stroke was ruled out. Numbness got better - still tingling. Flu shot reaction was not considered while hospitalized. Patient will discuss with her MD. Followed up with patient on 11/29/10: physician said it may be related to vaccine but since she is improving, they decided not to do the complicated testing involved. She is better, still has some weakness, uses a cane to steady her.
Neck pain/whiplash like neck pain/pain also moving up into neck / Neck tenderness persisted; severe nausea; pain down from injection site; pain down from injection site to in between 3rd and 4th fingers; pain also moving up into neck and upper spine that began; Neck pain/whiplash like neck pain/pain also moving up into neck / Neck tenderness persisted; This spontaneous report from a contactable Nurse (Patient).   A 33-year-old female patient (non-pregnant) received second dose BNT162B2 (PIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EN5318), via an unspecified route of administration, administered in Right arm on 02Feb2021 07:30 AM for COVID-19 immunisation. The patient medical history not reported. Concomitant medications included ibuprofen (The patient received ibuprofen within 2 weeks of vaccination). There were no allergies to medications, food, or other products. No known allergies. The patient did not receive any other vaccines within 4 weeks prior to COVID vaccine. Patient received first dose of BNT162B2 (PIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EL5249), via an unspecified route of administration, administered in Right arm on 12 Jan 2021 09:00 AM for COVID-19 immunisation. On 02Feb2021, 9:30PM, the patient had neck pain stemmed from injection site approximately 14h post vaccination, along with severe nausea. 24h post vaccination whiplash like neck pain that lasted approximately 24h. Neck tenderness persisted, although not severe after 24H. "Tingly" pain down from injection site to in between 3rd and 4th fingers, pain also moving up into neck and upper spine that began about 4 days post vaccination. Unable to get relief with Tylenol, Motrin or muscle relaxers. At the time of this report event outcome was not recovered.
Patient returned to the clinic today and reported the symptoms to me, onset was next day with chills, fever (unk), body aches, very sore injection site, very tender to touch, red, swollen.  Symptoms last 36 hours.
a patient inadvertently received ADACEL instead of DTAP with no reported adverse event; Initial information received on 24-Jan-2022 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 1 years old female patient who inadvertently received Adacel instead of DTAP with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included INFLUENZA VACCINE (FLUZONE [INFLUENZA VACCINE]) for Immunization; and PNEUMOCOCCAL VACCINE (PNEUMOCOCCAL VACCINE) for Immunization.  On 07-Dec-2021, the patient received a dose of 0.5 ml of suspect DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE (formulation, strength: unknown) lot U6830AA via intramuscular route in the left thigh as Immunisation.  On 07-DEC-2021 the patient developed a non-serious event "a patient inadvertently received Adacel instead of DTAP with no reported adverse event" (wrong product administered) same day following the administration of DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE..  It was reported" Caller reporting the nurse who administered the vaccine was unsure of which patient received the ADACEL, it was between two patients. Caller reporting the nurse was falsifying records, she had a pocket full of vials at the end of the day and had to sort out who received what vaccination."  Action taken with DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE (ADACEL) was not applicable.  It was not reported if the patient received a corrective treatment for the event (a patient inadvertently received ADACEL instead of DTAP with no reported adverse event).  At time of reporting, the outcome was Unknown for the event a patient inadvertently received Adacel instead of DTAP with no reported adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Tenderness at local sight; Radiating pain down back of arm to elbow; fingers going number; only able to lift arm 1/3 of the way up; fever and chills. Pt taking Ibuprofen to alleviate symptoms (all symptoms on left arm) and using heating pad.
Hospitalized 11/17/2021; COVID-19 positive 11/17/2021; fully vaccinated   Discharge Physician:  MD, MPH  Primary Care Physician: MD   Date of Admission: 11/17/2021, Hospital Day: 5  Discharge Date: 11/21/2021  DETAILS OF HOSPITAL STAY:   PRESENTING PROBLEM: Pneumonia due to COVID-19 virus  COVID-19    HOSPITAL COURSE: 67-year-old female past medical history coronary artery disease s/p CABG, chronic obstructive pulmonary disease, chronic diastolic CHF presents with cough and shortness of breath. In the ER patient was 88% on room air and required 3L NC. She had fairly stable vitals and labs other than her hypoxia. BNP and procalcitonin were WNL. She had CXR showing Mild peripherally predominant bilateral airspace disease concerning for pneumonitis. She was wheezing in the ER and started on solumedrol and albuterol for her breathing. She will be admitted to the hospitalist service for further treatment of COVID pneumonia and COPD exacerbation.  She was continued on dexamethasone and Remdesivir.  Supplemental oxygen was continued and weaned as tolerated.  Patient was continued on chronic obstructive pulmonary disease inhalers and other medications.  Patient's oxygen was weaned and home oxygen evaluation was performed by respiratory therapy.  Patient qualified for 3 L supplemental oxygen with exertion.  Inhalers were adjusted for chronic obstructive pulmonary disease.  PT OT evaluated advised home with assist home health PT/OT.  Case manager consulted to arrange for outpatient services and discharge planning. Patient clinically improved and hemodynamically stable for discharge.  Discussed plan of care discharge with patient including outpatient follow-up PCP within 7 days.  She will continue 5 additional days of dexamethasone and antitussives as well as mucolytics.  She will continue Lasix low-dose twice daily oral.  Patient will continue adjusted inhaler regimen for chronic obstructive pulmonary disease. Patient voiced understanding was agreeable with plan of care discharge.
pt recv vax & was apprehensive upon entering exam room & had been crying-took shots well;administered brother shot while watched then pt became unsteady on feet, fell back & became cyanotic-hit back of head on floor;BP 80/60;lethargic;to ER